Dr. Reddy's Zytorvi Secures DCGI Approval for Advanced Esophageal Cancer Treatment
Dr. Reddy's Laboratories receives DCGI approval for Zytorvi for advanced esophageal cancer treatment in India. The drug reduced death risk by 42% in trials.
Oncology
Latest Oncology stock news from NSE and BSE filings, 7 stories so far.
Product Launched
Zydus Lifesciences and Apollo Hospitals Partner to Launch Shield Multi-Cancer Detection Test
Zydus Lifesciences signs MoU with Apollo Hospitals to launch the Shield™ Multi-Cancer Detection test in India, targeting 10 cancer types via single blood draw.
Production Started
Shilpa Medicare Commissions Integrated ADC Manufacturing Facility in Dharwad
Shilpa Medicare commissions a state-of-the-art ADC GMP manufacturing facility in Dharwad. The new plant enhances CDMO capabilities in the oncology space.
Expansion
Shilpa Medicare Subsidiary Commissions Integrated ADC GMP Facility in Dharwad
Shilpa Medicare subsidiary Shilpa Biologicals commissions an ADC GMP facility in Dharwad; the parent company reports a TTM revenue of 1,538.14 crore rupees.
Product Launched
Dr. Reddy's Launches First Generic Bosulif in US Market for $253.8M Opportunity
Dr. Reddy's Laboratories launches generic Bosutinib Tablets 400mg in the U.S. with 180-day exclusivity, targeting a $253.8 million annual brand market size.
